Pancreatic IPMNs harbor genetic alterations of KRAS [10], [11], p16INK4[12], p53 [13], and DPC4/SMAD4/MADH4 [12]. This evidence concerns the gene KRAS and pancreatic intraductal papillary-mucinous neoplasm.